Cacci E, Villa A, Parmar M, Cavallaro M, Mandahl N, Lindvall O, Martinez-Serrano A, Kokaia Z
Laboratory of Neural Stem Cell Biology, Section of Restorative Neurology, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, BMC B10, Klinikgatan 26, University Hospital, SE-221 84 Lund, Sweden.
Exp Cell Res. 2007 Feb 1;313(3):588-601. doi: 10.1016/j.yexcr.2006.11.001. Epub 2006 Nov 7.
Isolation and expansion of neural stem cells (NSCs) of human origin are crucial for successful development of cell therapy approaches in neurodegenerative diseases. Different epigenetic and genetic immortalization strategies have been established for long-term maintenance and expansion of these cells in vitro. Here we report the generation of a new, clonal NSC (hc-NSC) line, derived from human fetal cortical tissue, based on v-myc immortalization. Using immunocytochemistry, we show that these cells retain the characteristics of NSCs after more than 50 passages. Under proliferation conditions, when supplemented with epidermal and basic fibroblast growth factors, the hc-NSCs expressed neural stem/progenitor cell markers like nestin, vimentin and Sox2. When growth factors were withdrawn, proliferation and expression of v-myc and telomerase were dramatically reduced, and the hc-NSCs differentiated into glia and neurons (mostly glutamatergic and GABAergic, as well as tyrosine hydroxylase-positive, presumably dopaminergic neurons). RT-PCR analysis showed that the hc-NSCs retained expression of Pax6, Emx2 and Neurogenin2, which are genes associated with regionalization and cell commitment in cortical precursors during brain development. Our data indicate that this hc-NSC line could be useful for exploring the potential of human NSCs to replace dead or damaged cortical cells in animal models of acute and chronic neurodegenerative diseases. Taking advantage of its clonality and homogeneity, this cell line will also be a valuable experimental tool to study the regulatory role of intrinsic and extrinsic factors in human NSC biology.
分离和扩增人源神经干细胞(NSCs)对于神经退行性疾病细胞治疗方法的成功开发至关重要。已经建立了不同的表观遗传和基因永生化策略,用于在体外长期维持和扩增这些细胞。在此,我们报告了一种基于v-myc永生化的、源自人胎儿皮质组织的新的克隆性NSC(hc-NSC)系的产生。通过免疫细胞化学,我们表明这些细胞在传代50多次后仍保留NSCs的特征。在增殖条件下,当补充表皮生长因子和碱性成纤维细胞生长因子时,hc-NSCs表达神经干/祖细胞标志物,如巢蛋白、波形蛋白和Sox2。当撤出生长因子时,v-myc和端粒酶的增殖和表达显著降低,hc-NSCs分化为神经胶质细胞和神经元(主要是谷氨酸能和γ-氨基丁酸能神经元,以及酪氨酸羟化酶阳性、推测为多巴胺能神经元)。RT-PCR分析表明,hc-NSCs保留了Pax6、Emx2和Neurogenin2的表达,这些基因与大脑发育过程中皮质前体细胞的区域化和细胞分化相关。我们的数据表明,这种hc-NSC系可能有助于探索人NSCs在急性和慢性神经退行性疾病动物模型中替代死亡或受损皮质细胞的潜力。利用其克隆性和同质性,该细胞系也将成为研究内在和外在因素在人NSC生物学中调节作用的有价值的实验工具。